Concepedia
Statistics
Publications
36
Citations
3.9K
H-Index
25
Active since
1993
Affiliations
Eli Lilly (United States)(Current)
University of Notre Dame
Indiana University School of Medicine
University of Alabama at Birmingham
National Institute of Allergy and Infectious Diseases
Michael D. Knierman is an author at Eli Lilly (United States) specializing in medicine, biochemistry, and natural sciences.
Top concepts
MedicineBiochemistryNatural SciencesBioanalysisProteomicsMass SpectrometryPharmacologyMolecular BiologyAnalytical ChemistryImmunology
Publications per year
1993–2022
Ghrelin octanoylation mediated by an orphan lipid transferase
Jesus A. Gutierrez, Patricia J. Solenberg, Douglas Perkins et al. · Proceedings of the National Academy of Sciences · 2008 · 801 citations · Full text
Caprine, Chemical Biology, Orphan Lipid Transferase +17
Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor
Amy C. Porter, John‐Michael Sauer, Michael D. Knierman et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 609 citations
FGF‐21/FGF‐21 receptor interaction and activation is determined by βKlotho
Alexei Kharitonenkov, James D. Dunbar, Holly A. Bina et al. · Journal of Cellular Physiology · 2007 · 318 citations
Metabolic Syndrome, Insulin Signaling, Signal Transduction +14
Comprehensive Label-Free Method for the Relative Quantification of Proteins from Biological Samples
Richard E. Higgs, Michael D. Knierman, Valentina Gelfanova et al. · Journal of Proteome Research · 2005 · 217 citations
The Novel Apolipoprotein A5 Is Present in Human Serum, Is Associated with VLDL, HDL, and Chylomicrons, and Circulates at Very Low Concentrations Compared with Other Apolipoproteins
Peter J. O’Brien, William E. Alborn, John H. Sloan et al. · Clinical Chemistry · 2004 · 209 citations · Full text
1–5 of 36